Mechanistic insights into the beneficial effects of curcumin on insulin resistance: Opportunities and challenges

Drug Discov Today. 2023 Jul;28(7):103627. doi: 10.1016/j.drudis.2023.103627. Epub 2023 May 22.

Abstract

The past couple of decades in particular have seen a rapid increase in the prevalence of type 2 diabetes mellitus (T2DM), a debilitating metabolic disorder characterised by insulin resistance. The insufficient efficacy of current management strategies for insulin resistance calls for additional therapeutic options. The preponderance of evidence suggests potential beneficial effects of curcumin on insulin resistance, while modern science provides a scientific basis for its potential applications against the disease. Curcumin combats insulin resistance by increasing the levels of circulating irisin and adiponectin, activating PPARγ, suppressing Notch1 signalling, and regulating SREBP target genes, among others. In this review, we bring together the diverse areas pertaining to our current understanding of the potential benefits of curcumin on insulin resistance, associated mechanistic insights, and new therapeutic possibilities.

Keywords: PPARγ; adiponectin; curcumin; insulin resistance; irisin.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adiponectin
  • Curcumin* / pharmacology
  • Curcumin* / therapeutic use
  • Diabetes Mellitus, Type 2* / drug therapy
  • Diabetes Mellitus, Type 2* / metabolism
  • Humans
  • Insulin
  • Insulin Resistance* / physiology
  • PPAR gamma / therapeutic use

Substances

  • Curcumin
  • Adiponectin
  • PPAR gamma
  • Insulin